Hemoglobin M disease

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:330041OMIM:617971D74.0
Who is this for?
Show terms as
16Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Hemoglobin M disease is a rare inherited blood disorder in which an abnormal form of hemoglobin, called hemoglobin M, is present in the red blood cells. Hemoglobin is the protein in red blood cells that carries oxygen throughout your body. In this condition, a genetic mutation changes the hemoglobin molecule so that the iron within it gets locked in a form called methemoglobin. Methemoglobin cannot carry oxygen effectively. This leads to a condition called methemoglobinemia, where the blood has a reduced ability to deliver oxygen to the body's tissues. The most noticeable symptom of hemoglobin M disease is cyanosis — a bluish or slate-gray discoloration of the skin, lips, and nail beds — that is present from birth or early infancy. Despite this alarming appearance, most people with hemoglobin M disease are surprisingly well and do not experience severe health problems. The cyanosis occurs because of the brownish color of methemoglobin in the blood rather than because of dangerously low oxygen levels. Some individuals may experience mild shortness of breath or fatigue, especially during exercise, but many people live normal, healthy lives. There is no specific cure for hemoglobin M disease, and in most cases, treatment is not necessary because the condition is generally benign. Unlike other forms of methemoglobinemia, hemoglobin M disease does not respond well to methylene blue, which is the standard treatment for acquired or other genetic forms of methemoglobinemia. The most important aspect of management is accurate diagnosis to avoid unnecessary treatments and to provide reassurance to patients and families.

Also known as:

Key symptoms:

Bluish or grayish skin color (cyanosis) present from birthBlue or dark-colored lipsBlue or dusky fingernails and toenailsBrownish-colored bloodMild shortness of breath during exerciseMild fatigue or reduced exercise toleranceSlate-gray skin tone that does not improve with oxygen therapy

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Hemoglobin M disease.

View clinical trials →

No actively recruiting trials found for Hemoglobin M disease at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Hemoglobin M disease community →

Specialists

16 foundView all specialists →
YC
Yong Cheng
DALLAS, TX
Specialist
1 Hemoglobin M disease publication
PB
Prathik Bandiya
Specialist
1 Hemoglobin M disease publication
CK
Chandana Kakumanu
Specialist
1 Hemoglobin M disease publication
KN
Ketaki Nawlakhe
Specialist
1 Hemoglobin M disease publication
NY
Na Yao
COSTA MESA, CA
Specialist
1 Hemoglobin M disease publication
JG
Jianrong Guo
Specialist
1 Hemoglobin M disease publication
AS
Aishwarya Sindhur
Specialist
1 Hemoglobin M disease publication
YS
Yuhong Shen
Specialist
1 Hemoglobin M disease publication
LY
Laiwei You
Specialist
1 Hemoglobin M disease publication
ZL
Zhenzhou Li
Specialist
1 Hemoglobin M disease publication
FM
Fareeda Hosein, MD
HAMILTON, NJ
Specialist
PI on 1 active trial
SW
Shuangshuang Wu
Specialist
1 Hemoglobin M disease publication
LH
Lili He
Specialist
1 Hemoglobin M disease publication
CL
Chunhuai Li
Specialist
1 Hemoglobin M disease publication
LX
Lu Xue
SPRINGFIELD, OH
Specialist
1 Hemoglobin M disease publication
YW
Yue Wang
Specialist
1 Hemoglobin M disease publication

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Hemoglobin M disease.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Hemoglobin M diseaseForum →

No community posts yet. Be the first to share your experience with Hemoglobin M disease.

Start the conversation →

Latest news about Hemoglobin M disease

No recent news articles for Hemoglobin M disease.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Which specific hemoglobin M variant does my family member have, and which gene is affected?,Are there any medications or substances we should avoid that could worsen the methemoglobinemia?,Should other family members be tested for this condition?,Are there any activity restrictions, or can my child participate in sports normally?,What should I tell emergency room doctors if we need urgent care for an unrelated problem?,Is genetic counseling recommended for future family planning?,How often should follow-up blood tests or check-ups be done?

Common questions about Hemoglobin M disease

What is Hemoglobin M disease?

Hemoglobin M disease is a rare inherited blood disorder in which an abnormal form of hemoglobin, called hemoglobin M, is present in the red blood cells. Hemoglobin is the protein in red blood cells that carries oxygen throughout your body. In this condition, a genetic mutation changes the hemoglobin molecule so that the iron within it gets locked in a form called methemoglobin. Methemoglobin cannot carry oxygen effectively. This leads to a condition called methemoglobinemia, where the blood has a reduced ability to deliver oxygen to the body's tissues. The most noticeable symptom of hemoglobi

How is Hemoglobin M disease inherited?

Hemoglobin M disease follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Hemoglobin M disease typically begin?

Typical onset of Hemoglobin M disease is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Hemoglobin M disease?

16 specialists and care centers treating Hemoglobin M disease are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.